Literature DB >> 10070272

Cryoglobulinaemia and rheumatic manifestations in patients with hepatitis C virus infection.

Y H Lee1, J D Ji, J E Yeon, K S Byun, C H Lee, G G Song.   

Abstract

OBJECTIVES: To investigate the association of cryoglobulinaemia and rheumatic manifestations in Korean patients with hepatitis C virus (HCV) infection.
METHODS: Forty nine Korean patients with HCV infection were recruited. The prevalence, concentration, and type of cryoglobulin (by immunofixation), rheumatoid factor (RF), antinuclear antibody (ANA), and various rheumatological symptoms were investigated and HCV genotype was determined by polymerase chain reaction with genotype specific primer.
RESULTS: The prevalence of cryoglobulin was 59% in Korean HCV patients and the concentration of cryoglobulin was 9.8 (7.9) g/l (mean (SD)). The type of cryoglobulinaemia was identified in 23 (80%) of 29 HCV patients with cryoglobulinaemia and they were all type III. There were no differences in age, sex, history of operation and transfusion, proportion of liver cirrhosis between the patients with cryoglobulinaemia and those without cryoglobulinaemia. The frequencies of RF and ANA were 14% and 3.4% respectively in HCV patients with cryoglobulinaemia. There was no difference in HCV genotype between the patients with cryoglobulinaemia and those without cryoglobulinaemia. Clinical features of HCV patients were as follows: arthralgia/arthritis (35%), cutaneous manifestation (37%), Raynaud's phenomenon (8%), paresthesia (44%), dry eyes (22%), dry mouth (10%), oral ulcer (33%), and abdominal pain (14%). However, these rheumatological symptoms did not differ between the two groups.
CONCLUSION: Although the rheumatological symptoms were not different between HCV patients with and without cryoglobulinaemia, HCV patients showed various rheumatological manifestations. These result suggests that HCV infection could be included as one of the causes in patients with unexplained rheumatological symptoms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10070272      PMCID: PMC1752516          DOI: 10.1136/ard.57.12.728

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  31 in total

1.  Cryoglobulinemia--a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity.

Authors:  M Meltzer; E C Franklin; K Elias; R T McCluskey; N Cooper
Journal:  Am J Med       Date:  1966-06       Impact factor: 4.965

2.  Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease.

Authors:  G Dusheiko; H Schmilovitz-Weiss; D Brown; F McOmish; P L Yap; S Sherlock; N McIntyre; P Simmonds
Journal:  Hepatology       Date:  1994-01       Impact factor: 17.425

3.  Infection of peripheral mononuclear blood cells by hepatitis C virus.

Authors:  A L Zignego; D Macchia; M Monti; V Thiers; M Mazzetti; M Foschi; E Maggi; S Romagnani; P Gentilini; C Bréchot
Journal:  J Hepatol       Date:  1992-07       Impact factor: 25.083

4.  A role for hepatitis C virus infection in type II cryoglobulinemia.

Authors:  V Agnello; R T Chung; L M Kaplan
Journal:  N Engl J Med       Date:  1992-11-19       Impact factor: 91.245

5.  Differences in the hepatitis C virus genotypes in different countries.

Authors:  N Takada; S Takase; A Takada; T Date
Journal:  J Hepatol       Date:  1993-03       Impact factor: 25.083

6.  Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis.

Authors:  M R Lovy; G Starkebaum; S Uberoi
Journal:  J Rheumatol       Date:  1996-06       Impact factor: 4.666

7.  Hepatitis C virus infection in patients with essential mixed cryoglobulinemia.

Authors:  R Misiani; P Bellavita; D Fenili; G Borelli; D Marchesi; M Massazza; G Vendramin; B Comotti; E Tanzi; G Scudeller
Journal:  Ann Intern Med       Date:  1992-10-01       Impact factor: 25.391

8.  Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants.

Authors:  S W Chan; F McOmish; E C Holmes; B Dow; J F Peutherer; E Follett; P L Yap; P Simmonds
Journal:  J Gen Virol       Date:  1992-05       Impact factor: 3.891

9.  Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources.

Authors:  H Okamoto; Y Sugiyama; S Okada; K Kurai; Y Akahane; Y Sugai; T Tanaka; K Sato; F Tsuda; Y Miyakawa
Journal:  J Gen Virol       Date:  1992-03       Impact factor: 3.891

10.  Prevalence of hepatitis C virus antibody among Korean adults.

Authors:  Y S Kim; C H Pai; H S Chi; D W Kim; Y I Min; Y O Ahn
Journal:  J Korean Med Sci       Date:  1992-12       Impact factor: 2.153

View more
  14 in total

1.  Mixed cryoglobulinaemia after hepatitis C virus: more and less ambiguity.

Authors:  V Agnello
Journal:  Ann Rheum Dis       Date:  1998-12       Impact factor: 19.103

2.  Prevalence and clinical features of cryoglobulinaemia in multitransfused beta-thalassaemia patients.

Authors:  R Perniola; C De Rinaldis; E Accogli; G Lobreglio
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 3.  Extrahepatic manifestations of chronic hepatitis C virus infection.

Authors:  Patrice Cacoub; Cloe Comarmond; Fanny Domont; Léa Savey; Anne C Desbois; David Saadoun
Journal:  Ther Adv Infect Dis       Date:  2016-02

Review 4.  Cryoglobulinaemic vasculitis: classification and clinical and therapeutic aspects.

Authors:  Gerald S Braun; Sophia Horster; Katrin S Wagner; Stephan Ihrler; Holger Schmid
Journal:  Postgrad Med J       Date:  2007-02       Impact factor: 2.401

5.  Assessing rheumatologists and radiologists agreement rate regarding the diagnosis of focal bone erosions and osteopenic changes using hand X-rays radiography in patients with rheumatoid arthritis.

Authors:  Arman Ahmadzadeh; Pooneh Dehghan; Alireza Rajaee; Mohammadmehdi Emam; Katayoun Enteshari; Latif Gachkar
Journal:  Rheumatol Int       Date:  2013-02-05       Impact factor: 2.631

6.  Usefulness of anti-CCP antibodies in patients with hepatitis C virus infection with or without arthritis, rheumatoid factor, or cryoglobulinemia.

Authors:  Feng-Cheng Liu; You-Chen Chao; Tsung-Yun Hou; Hsiang-Cheng Chen; Rong-Yaun Shyu; Tsai-Yuan Hsieh; Chen-Hung Chen; Deh-Ming Chang; Jenn-Haung Lai
Journal:  Clin Rheumatol       Date:  2007-09-18       Impact factor: 2.980

7.  The Clinical Application of Anti-CCP in Rheumatoid Arthritis and Other Rheumatic Diseases.

Authors:  Ct Chou; Ht Liao; Ch Chen; Ws Chen; Hp Wang; Ky Su
Journal:  Biomark Insights       Date:  2007-05-03

8.  Hepatectomy for hepatocellular carcinoma complicated by vasculitis flare.

Authors:  Zeinab Abdi; Svetlana Krasnokutsky; Amy Rapkiewicz; Amit Saxena; Gerald Villanueva; Umut Sarpel
Journal:  HPB Surg       Date:  2010-09-01

Review 9.  Hepatitis C virus infection induced vasculitis.

Authors:  Patrice Cacoub; David Saadoun
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

10.  Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren's syndrome.

Authors:  D Sène; P Ghillani-Dalbin; N Limal; V Thibault; T van Boekel; J-C Piette; P Cacoub
Journal:  Ann Rheum Dis       Date:  2006-03       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.